The cost-effectiveness of infliximab (Remicade) in the treatment of ankylosing spondylitis in Canada. OBJECTIVE: To estimate the cost-effectiveness of the treatment of ankylosing spondylitis (AS) with infliximab (Remicade) in Canada over the long term, with... G Kobelt,P Andlin-Sobocki,WP Maksy...
The study highlights the safety, efficacy, and cost benefits of infliximab biosimilars in managing pediatric noninfectious uveitis, showing fewer disease flares and reduced costs compared with reference infliximab, as well as the influence of insurance mandates on treatment decisions....